Clinical Trials
4 trialsNCT05538897 2026-05-13
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT04604613 2026-03-09
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
M.D. Anderson Cancer Center
Active not recruiting
NCT06689956 2026-02-19
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
Mayo Clinic
Recruiting
NCT06213571 2026-01-09
Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas
Mayo Clinic
Phase NA Active not recruiting